跳至主要内容
临床试验/NCT03266926
NCT03266926已完成不适用

Does the Use of Bupivacaine Soaked Vaginal Packing Following Vaginal Surgery Decrease Postoperative Pain?

Sunnybrook Health Sciences Centre1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2017年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
140
试验地点
1
主要终点
Visual Analog Scale (VAS)

研究概览

简要总结

In current practice, packing in the vagina overnight after vaginal surgery is typically used to prevent post-surgical vaginal bleeding. The vaginal packing is usually coated with either estrogen cream or bupivacaine at the investigators' hospital . There are reports in the literature that show nasal packing soaked with local anesthetic after nasal sinus surgery reduces post-surgical pain. To date, no studies have evaluated local anesthetic soaked vaginal packing after vaginal surgery and if this is associated with a reduction in post-surgical pain scores.

The investigators seek to investigate if vaginal packing soaked with a local anesthetic reduces post-operative pain while providing the necessary action of minimizing potential post-surgical bleeding.

详细描述

This is a prospective cohort, single centre, single-blinded study looking at a population of women post vaginal surgery with vaginal packing that is either coated with estrogen cream or 0.25% Bupivacaine + epinephrine (local anesthetic). Patients who have booked vaginal surgery for prolapse repair will be invited to participate in this study. A document describing the study will be provided for reading and will include the consent for the study. At the end of surgery, a vaginal pack is placed to decrease potential bleeding post surgery. At this time, patients will receive either vaginal packing with estrogen, or, the vaginal packing with 0.25% bupivacaine + epinephrine, according to physician preference. Patients and the nurses caring for them post surgery will be blinded as to which group the patient has been assigned to. The nurses in the recovery room and post operative ward will ask patients post surgery the day of surgery, (POD#0, two and six hours post OR) and POD#1 to rate the patients' surgical pain with a standardized, validated VAS pain score. Secondary outcomes will be recorded: the amount of analgesics used in hospital after surgery, intra-operative blood loss, post operative hemoglobin, the number of days until the patient is able to void, the amount of analgesics used at home after surgery (patients will be asked to keep a record of the total number of oral analgesic pain tablets used and on which day post surgery they stopped using pain medications) and other post surgical complications. Data will be stored in a secure, password protected desktop on site. Each patient will be assigned a unique number which can be traced back to a master file which will include patient identifiers (name, MRN, DOB). Data will be analyzed with the appropriate statistical tests. There are no additional tests or visits for patients. Patient study assignment will be disclosed to them at the 6 week routine post surgical examination/assessment visit.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients of 4 attending physicians (urogynecologists) of Sunnybrook Health Sciences Centre planning to undergo a vaginal hysterectomy and/or vaginal reconstructive surgery for pelvic organ prolapse.
  • Subjects aged 18 years and older and able to provide informed consent

排除标准

  • Any patient undergoing abdominal prolapse repair or no vaginal repairs
  • Patients undergoing vaginal obliterative procedures
  • Patients with a known allergy or adverse reaction to Bupivacaine or contraindication to Premarin

研究组 & 干预措施

Postoperative Patients with bupivacaine

Patients who undergo vaginal surgery at Patients who undergo vaginal surgery (SHSC) who require vaginal packing postoperatively and receive bupivacaine soaked packing.

干预措施: Bupivacaine (Drug)

Postoperative Patients with premarin

Patients who undergo vaginal surgery at Sunnybrook Health Sciences Centre (SHSC) who require vaginal packing postoperatively and receive premarin vaginal cream coated packing.

干预措施: Premarin Vaginal cream (Drug)

结局指标

主要结局

Visual Analog Scale (VAS)

时间窗: The outcome measure will be assessed six hours postoperative

Primary outcome is postoperative pain score 6 hours post surgery on POD#0

次要结局

  • Postoperative Hemoglobin(Morning of postoperative day one)
  • Intraoperative Blood Loss(One time measurement, intra-operative)
  • Analgesic Use In Hospital(From when surgery ends to time of discharge from hospital post operative day 1)
  • Trial of Void(Up to six weeks postoperative)
  • Analgesic Use Postoperative(Up to six weeks postoperative)
  • Visual Analog Scale (VAS)(The outcome measure will be assessed on the morning of postoperative day one.)
  • Post-operative per vaginal blood loss(From when surgery ends to time of discharge from hospital post operative day 1)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验